Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,444
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Cleveland OH, Pittsburgh PA, Columbus OH, Detroit MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase 3, Recruiting
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
for
Amyloidosis; Systemic
Location: Cleveland OH, Baltimore MD, Philadelphia PA,
Sponsor: Attralus, Inc.
Sex: All
Age: 18+
Code: NCT05521022
Phase 1, Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Cleveland OH, Cincinnati OH, Bethesda MD, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05131022
Phase 1, Recruiting
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
for
Endometrial Cancer, Cervical Cancer,
Location: Cleveland OH, Detroit MI, Saginaw MI, Chicago IL,
Sponsor: Mayo Clinic
Sex: Female
Age: 18+
Code: NCT05051722
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Location: Cleveland OH, Washington DC, Louisville KY, Durham NC,
Sponsor: Potrero Medical
Sex: All
Age: 18+
Code: NCT04669548
Recruiting
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Cleveland OH, Nashville TN, Dallas TX, Duarte CA,
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT05361720
Phase 2, Recruiting
Multi-Center Clean Air Randomized Controlled Trial in COPD
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Cleveland OH, Ann Arbor MI, Baltimore MD,
Sponsor: JHSPH Center for Clinical Trials
Sex: All
Age: 40+
Code: NCT06376994
Phase 3, Recruiting
Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment
for
Gastrointestinal Complication
Location: Cleveland OH, Grand Rapids MI, Chicago IL,
Sponsor: Entac Medical Inc.
Sex: All
Age: 18 - 70+
Code: NCT04880473
Recruiting
HA35 Acute Alcohol Study
for
Healthy Controls
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 21 - 65
Code: NCT05025865
Early Phase 1, Recruiting
A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: Cleveland OH, Pittsburgh PA, Fort Wayne IN,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase 2, Recruiting
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy
for
Esophageal Cancer Surgery, Esophagectomy,
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT06721520
Phase 2, Phase 3, Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
for
Tremor Associated With Tremor Dominant Parkinson's Disease
Location: Cleveland OH, Fairborn OH, Chicago IL, Huntsville NC,
Sponsor: InSightec
Sex: All
Age: 30 - 70+
Code: NCT04991831
Recruiting
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
for
Narcolepsy Type 1
Location: Cleveland OH, Dublin OH, Novi MI, Cincinnati OH,
Sponsor: Takeda
Sex: All
Age: 16 - 70
Code: NCT05816382
Phase 2, Phase 3, Recruiting
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
for
Peripartum Cardiomyopathy, Postpartum
Location: Cleveland OH, Pittsburgh PA, Detroit MI, Ann Arbor MI,
Sponsor: Dennis M. McNamara, MD, MS
Sex: Female
Age: 18+
Code: NCT05180773
Recruiting
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis
Location: Cleveland OH, Ann Arbor MI, Baltimore MD,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT04485260
Phase 1, Phase 2, Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
for
In-Stent Restenosis, Cardiovascular Diseases,
Location: Cleveland OH, Morgantown WV, Pomona NJ, New York NY,